Comparison of ketamine and dexmedetomidine in a reduction of shoulder dislocation

Comparison the efficacy and side effects of ketamine and Dexmedetomidine in reduction of shoulder dislocation in patients referring to the emergency department of Ahwaz Imam Khomeini and Golestan Hospital in 2017

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180530039917N1

Enrollment

Registered

2018-06-21

Start date

2017-06-23

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dislocation of shoulder. Dislocation and sprain of joints and ligaments of shoulder girdle

Interventions

Intervention 1: The group will receive 1 Mg/Kg Ketamine nebulized. Intervention 2: The group will receive 1 micro gram/Kg Dexmedetomidine nebulized.

Eligibility

Sex/Gender

All

Age

14 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inferior and posterior dislocation of shoulder 14 - 65 aged

Exclusion criteria

Exclusion criteria: Patients with fracture in the primary graph Excessive injury or open dislocation shoulder Patients with reduced consciousness Patients with deformity and neurological lesions in shoulder

Design outcomes

Primary

Measure	Time frame
What is the mean value of VAS score in patients undergoing comorbid reduction of ketamine and doxedetomidine before the intervention at 5, 10, 20, 30 and 60 minutes after receiving the drug?. Timepoint: 0,5,10,20 30, 60 minutes after treatmen. Method of measurement: VAS questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPayam Ghoraian

Ahvaz University of Medical Sciences

ghoraian.p@ajums.ac.ir+98 21 8670 5503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026